Shalby Hospitals

Ahmedabad, India Founded: 1994 • Age: 32 yrs Listed
Multi-specialty hospital services are delivered through a chain in India.

About Shalby Hospitals

Shalby Hospitals is a publicly listed company based in Ahmedabad (India) founded in 1994 by Vikram Shah. Multi-specialty hospital services are delivered through a chain in India. The company has 2,497 employees. Shalby Hospitals has completed 2 acquisitions, including Sanar International Hospitals and Slaney Healthcare. Its chief executive, as recorded, is Ravi Bhandari. Its website shalby.org draws about 36 thousand monthly visits. Its Indian entity Shalby Limited reported revenue of β‚Ή1,168 Cr. Its focus areas include Hospital Chains and Multispecialty Hospital Chains. Similar companies include Fortis Healthcare, Ujala Cygnus and Narayana Health; 2 of its 3 listed similar companies have raised funding.

Company details

Shalby Hospitals was established in 1994 in Ahmedabad, India, as a chain of multi-specialty facilities. Healthcare services across various specialties are provided by the organization, with operations centered in India. The network focuses on medical treatments and patient care in urban and regional areas. Leadership is held by founder Vikram Shah and CEO Ravi Bhandari, supporting expansion in the healthcare sector.

  • Headquarters Ahmedabad, India
  • Employees 2,497
  • Founders Vikram Shah
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website shalby.org
  • Social LinkedIn X Facebook Instagram
  • Legal Name Shalby Ltd.
Key Metrics
  • Market Cap
    ₹1,317 Cr

    SHALBY · NSE

  • Share Price
    ₹122.15

    +0.21% today

  • Revenue
    ₹1,141 Cr

    FY 2025-26 · +5.0% YoY

  • EBITDA
    ₹145 Cr

    Margin 12.7%

  • Net Profit
    ₹24.48 Cr

    FY 2025-26 · +305.9% YoY

  • P/E (TTM)
    32.8x

    P/B 1.3x

  • ROE
    2.2%

    ROCE 6.1%

  • Debt / Equity
    0.54

    Interest cover 55.0x

  • Employee Count
    2,497
  • Investments & Acquisitions

Board of directors of Shalby Limited (Shalby Hospitals)

Shalby Limited is the primary company behind Shalby Hospitals. The boards of the 6 registered companies of Shalby Hospitals currently have 12 directors; the longest-serving is Shyamal Shivkumar Joshi, appointed in 2011. 42 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Shyamal Shivkumar Joshi
DIN 00005766
Director12 Aug 201115 yrs 3 moVrundavan Shalby Hospitals Limited, Shalby Medtech Limited, Shalby Limited
Shanay Vikram Shah
DIN 02726541
Director10 Oct 201115 yrs 1 moSlaney Healthcare Private Limited, Shalby Hospitals Mumbai Private Limited, Shalby International Limited
Ravi Bhandari
DIN 06395271
Director21 Nov 201214 yrsVrundavan Shalby Hospitals Limited, Slaney Healthcare Private Limited, Shalby International Limited
Darshini Vikram Shah
DIN 00013903
Director15 May 201412 yrs 6 moSlaney Healthcare Private Limited
Umesh Krishnankutty Menon
DIN 00086971
Director20 Dec 20169 yrs 11 moShalby Limited
Tej Ramjidass Malhotra
DIN 00122419
Director23 Feb 20179 yrs 8 moShalby Limited
Viral Bhalchandra Shah
DIN 02928038
Managing Director15 Sep 20179 yrs 2 moVrundavan Shalby Hospitals Limited, Slaney Healthcare Private Limited
Ashok Bhatia
DIN 02090239
Director23 Oct 20179 yrsShalby Limited
Sujana Manan Shah
DIN 08100410
Director03 Apr 20206 yrs 7 moShalby Medtech Limited, Shalby Limited
Vikram Indrajit Shah
DIN 00011653
Managing Director03 Apr 20206 yrs 7 moShalby Medtech Limited, Shalby Limited, Shalby Hospitals Mumbai Private Limited, Shalby International Limited
Tushar Dineshchandra Shah
DIN 06739455
Company Secretary07 Sep 20215 yrs 2 moShalby Medtech Limited
Babu Thomas
DIN 10669722
Director15 Jun 20242 yrs 5 moShalby Hospitals Mumbai Private Limited

People of Shalby Hospitals

42 people are tracked at Shalby Hospitals (12 in leadership, 30 in team); the tracked headcount is 2,497.

NameRoleGroup
FounderLeadership
CEOLeadership
Anith Sankaran
Head Of Supply Chain Management & Operations- GlobalLeadership
Nilesh Soni
Vice PresidentLeadership
Amit Nerurkar
Chief Information OfficerLeadership
Shivam Mahor
Head Of Sales MarketingLeadership
Deepak Ananthakrishnan
Chief Business Officer - GlobalLeadership
Amit Pathak
Group Chief Financial OfficerLeadership
Ajay Kumar Rao
Associate Vice PresidentLeadership
Associate Vice President & Company SecretaryLeadership
Siddhartha Pandey
Associate Vice President - Supply ChainLeadership
Masila Mani
Associate Vice President - Learning & Development | Business Head Shalby AcademyLeadership
Shashwat Sood
Sr Manager Corporate DevelopmentTeam
Pradeep Jayswal
Assistant Manager Human ResourcesTeam
Gladwin Nayyar
CAOTeam
Sana Siddique
Patient Relation OfficerTeam
Mohan Rabari
Senior Executive Supply Chain ManagementTeam
Kishan Pandya
Purchase ExecutiveTeam
Madhur Awasthi
Supply Chain ManagerTeam
Mamta Chouhan
Senior ExecutiveTeam

22 more people are available in the full profile.

Premium access

Complete people profiles for Shalby Hospitals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Shalby Hospitals

Shalby Hospitals is a publicly listed company on the NSE with ticker symbol SHALBY in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date15 Dec 2017
  • Listed onBSE: 540797 · NSE: SHALBY
  • Listed entityShalby Ltd.
  • Exchange sectorHealth services
  • ISININE597J01018
  • Share price₹133.02 (+0.53% on the day) · 2026-10-14
  • Market capitalisation₹1,435 Cr
  • Price to earnings36.1
  • EPS (diluted, trailing year)₹3.68
  • Volume (last session)14,196

Financials of Shalby Hospitals

Exchange-reported figures of Shalby Limited, the listed company behind Shalby Hospitals (NSE: SHALBY).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹1,141 Cr
+5.0% YoY
EBITDA
₹145 Cr
+7.7% YoY
Profit After Tax
₹24.48 Cr
+305.9% YoY
Net Worth
₹1,005 Cr
+1.3% YoY
Total Assets
₹1,615 Cr
+8.7% YoY
Total Debt
₹595 Cr
+24.9% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,1411,087934805699431487
Revenue growth+5.0%+16.4%+16.0%+15.2%+62.2%-11.5%-
EBITDA14513517913811787.3382.77
EBITDA margin+12.7%+12.4%+19.1%+17.2%+16.8%+20.3%+17.0%
Profit before tax60.5455.7312810279.1655.0556.71
Net profit24.48(11.89)79.2666.5256.0343.1927.15
Net profit margin+2.1%-1.1%+8.5%+8.3%+8.0%+10.0%+5.6%
EPS (β‚Ή)3.480.587.836.315.013.932.55
Balance sheet
Total assets1,6151,4861,4001,1221,058901879
Net worth1,0059921,000928876835799
Total debt59547637818015544.0362.21
Cash & bank21.9434.8627.2312.2911183.5728.73
Net working capital482409299256321182136
Cash flow
Cash from operations(0.01)(4.34)19.6067.7818.9279.1555.37
Cash from investing(97.28)(35.64)146(61.08)(60.28)(51.27)(30.67)
Cash from financing84.4147.58(151)(50.00)90.46(29.86)(21.50)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue313331287272285296265276
Revenue growth (YoY)+9.7%+11.7%+8.5%-1.3%+6.7%+6.3%--
Other income5.047.418.087.234.487.015.325.42
EBITDA41.3941.5929.3530.2641.6141.5420.8433.90
EBITDA margin+13.2%+12.6%+10.2%+11.1%+14.6%+14.0%+7.9%+12.3%
Depreciation18.9218.7418.4917.6117.3716.5216.2316.32
Interest11.0510.579.3410.649.659.3710.6710.66
Profit before tax16.4619.699.609.2419.0722.66(0.74)12.34
Tax8.599.20(8.85)7.9511.8014.9711.4515.34
Net profit7.8710.4918.451.297.277.69(12.19)(3.00)
EPS (β‚Ή)0.730.981.720.120.680.71(1.13)(0.28)
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue899869830708647419484
Revenue growth+3.4%+4.7%+17.2%+9.5%+54.5%-13.5%-
EBITDA14615717914312787.0382.54
EBITDA margin+16.2%+18.1%+21.6%+20.2%+19.6%+20.8%+17.1%
Profit before tax11613615812199.9255.4857.01
Net profit10872.5698.7779.6171.9543.3427.53
Net profit margin+12.0%+8.4%+11.9%+11.2%+11.1%+10.4%+5.7%
EPS (β‚Ή)10.507.809.677.536.463.972.59
Balance sheet
Total assets1,3921,2561,1961,016970915894
Net worth1,2471,1341,062970907850814
Total debt13111012134.0841.3144.0362.21
Cash & bank13.3921.669.233.3210482.9728.71
Net working capital17812910582.03250183139
Cash flow
Cash from operations91.1914914016510177.2457.09
Cash from investing(109)(101)(206)(172)(40.32)(51.83)(32.28)
Cash from financing9.16(35.80)72.14(38.21)(17.25)(27.82)(21.50)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue245254225214224237207221
Revenue growth (YoY)+9.5%+7.2%+8.6%-3.2%+5.5%+1.7%--
Other income5.295.285.597.515.815.527.196.28
Total expenses205211194186185190176178
EBITDA40.4042.4930.7627.9138.9746.8430.7742.53
EBITDA margin+16.5%+16.7%+13.7%+13.1%+17.4%+19.8%+14.9%+19.3%
Depreciation10.9510.8010.5310.009.949.689.639.94
Interest3.193.082.363.554.282.582.663.09
Profit before tax31.5533.8923.4621.8730.5640.1025.6735.78
Tax8.058.82(30.21)8.0910.8114.4110.7214.91

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 21 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue313331287272285296265276
Revenue growth (YoY)+9.7%+11.7%+8.5%-1.3%+6.7%+6.3%--
Other income5.047.418.087.234.487.015.325.42
EBITDA41.3941.5929.3530.2641.6141.5420.8433.90
EBITDA margin+13.2%+12.6%+10.2%+11.1%+14.6%+14.0%+7.9%+12.3%
Depreciation18.9218.7418.4917.6117.3716.5216.2316.32
Interest11.0510.579.3410.649.659.3710.6710.66
Profit before tax16.4619.699.609.2419.0722.66(0.74)12.34
Tax8.599.20(8.85)7.9511.8014.9711.4515.34
Net profit7.8710.4918.451.297.277.69(12.19)(3.00)
EPS (β‚Ή)0.730.981.720.120.680.71(1.13)(0.28)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,1411,087934805699431487
Revenue growth+5.0%+16.4%+16.0%+15.2%+62.2%-11.5%-
Other income26.7927.6019.4322.5212.429.0617.37
Total expenses996952755667582344404
Employee cost18818515514411856.9665.50
EBITDA14513517913811787.3382.77
EBITDA margin+12.7%+12.4%+19.1%+17.2%+16.8%+20.3%+17.0%
Depreciation69.9965.7652.2448.0942.8736.8036.02
Interest41.3340.8417.6210.567.534.547.41
Profit before tax60.5455.7312810279.1655.0556.71
Tax25.8753.8144.7034.3725.1712.6929.14
Net profit24.48(11.89)79.2666.5256.0343.1927.15
Net profit margin+2.1%-1.1%+8.5%+8.3%+8.0%+10.0%+5.6%
EPS (β‚Ή)3.480.587.836.315.013.932.55
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital108107107107108108108
Reserves & surplus898885893820768727691
Shareholders' funds (net worth)1,0059921,000928876835799
Minority interest0.463.147.41(0.07)(0.14)0.020.05
Secured loans54042731314215544.0348.67
Unsecured loans54.9749.2164.7238.830.000.0013.54
Total debt59547637818015544.0362.21
Total liabilities1,6151,4861,4001,1221,058901879
Assets
Gross block1,4821,3291,285910860804782
Net block1,046955966685675660672
Capital work in progress18.8121.9715.3910.555.777.526.39
Investments62.2694.6380.6414624.7015.6327.99
Inventories38532423718512123.0515.22
Sundry debtors22817514510610194.6994.86
Cash & bank balances21.9434.8627.2312.2911183.5728.73
Loans & advances30.3334.0564.5667.4793.6054.3567.04
Total current assets666569473372426256206
Total current liabilities18416017411510573.2169.72
Net working capital482409299256321182136
Total assets1,6151,4861,4001,1221,058901879
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash34.7927.1812.2455.556.488.465.26
Net cash from operating activities(0.01)(4.34)19.6067.7818.9279.1555.37
Net cash from investing activities(97.28)(35.64)146(61.08)(60.28)(51.27)(30.67)
Net cash from financing activities84.4147.58(151)(50.00)90.46(29.86)(21.50)
Net change in cash(12.88)7.6114.94(43.31)49.10(1.98)3.21
Closing cash21.9434.8627.2312.2911183.5728.73
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+5.0%+16.4%+16.0%+15.2%+62.2%-11.5%-
EBITDA growth+7.7%-24.6%+29.3%+18.0%+34.1%+5.5%-
PBT growth+8.6%-56.5%+25.6%+28.9%+43.8%-2.9%+12.5%
Net income growth+305.9%-115.0%+19.2%+18.7%+29.7%+59.1%-
Revenue CAGR (3Y)+12.4%+15.9%+29.4%+18.3%+14.8%+4.5%+14.6%
EBITDA CAGR (3Y)+1.6%+4.8%+26.9%+18.6%+12.0%+3.4%+5.0%
Profitability & leverage
Net income margin+3.0%+0.2%+8.9%+8.4%+7.7%+9.8%+5.7%
Return on capital employed+6.1%+6.1%+11.6%+10.3%+8.9%+6.7%+7.4%
Return on net worth+2.2%-1.6%+8.7%+7.5%+6.3%+5.2%+3.5%
Debt / equity0.540.430.290.190.120.070.08
Long-term debt / equity0.190.200.170.100.070.050.07
Interest cover55.0559.2113.9411.7210.148.9815.85
Efficiency & per share
Fixed asset turnover0.810.830.850.910.840.540.63
Inventory turnover3.223.874.425.259.6922.5234.74
Debtors turnover5.666.807.447.767.144.555.53
EPS (β‚Ή)3.480.587.836.315.013.932.55
Dividend per share (β‚Ή)0.000.001.201.201.001.000.50
Book value per share (β‚Ή)93.4992.3193.1386.4581.1377.2874.00
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue245254225214224237207221
Revenue growth (YoY)+9.5%+7.2%+8.6%-3.2%+5.5%+1.7%--
Other income5.295.285.597.515.815.527.196.28
Total expenses205211194186185190176178
EBITDA40.4042.4930.7627.9138.9746.8430.7742.53
EBITDA margin+16.5%+16.7%+13.7%+13.1%+17.4%+19.8%+14.9%+19.3%
Depreciation10.9510.8010.5310.009.949.689.639.94
Interest3.193.082.363.554.282.582.663.09
Profit before tax31.5533.8923.4621.8730.5640.1025.6735.78
Tax8.058.82(30.21)8.0910.8114.4110.7214.91
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue899869830708647419484
Revenue growth+3.4%+4.7%+17.2%+9.5%+54.5%-13.5%-
Other income24.8630.2720.7019.5713.009.6217.74
Total expenses753712651565520332401
Employee cost11210998.0586.7678.3255.7465.25
EBITDA14615717914312787.0382.54
EBITDA margin+16.2%+18.1%+21.6%+20.2%+19.6%+20.8%+17.1%
Depreciation40.1538.8937.0837.0635.5036.6735.86
Interest14.4812.664.324.444.404.507.41
Profit before tax11613615812199.9255.4857.01
Tax3.0951.9554.4740.5530.1112.6129.06
Net profit10872.5698.7779.6171.9543.3427.53
Net profit margin+12.0%+8.4%+11.9%+11.2%+11.1%+10.4%+5.7%
EPS (β‚Ή)10.507.809.677.536.463.972.59
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital108107107107108108108
Reserves & surplus1,1391,027955863799742706
Shareholders' funds (net worth)1,2471,1341,062970907850814
Secured loans12010311425.5041.3144.0348.67
Unsecured loans11.726.677.468.580.000.0013.54
Total debt13111012134.0841.3144.0362.21
Total liabilities1,3921,2561,1961,016970915894
Assets
Gross block950868851817806802779
Net block621579599603628658670
Capital work in progress0.268.045.2410.055.747.526.39
Investments62359951131362.0932.1042.75
Inventories24.6620.2519.2019.6219.8319.9414.76
Sundry debtors18013211889.6494.3093.0091.49
Cash & bank balances13.3921.669.233.3210482.9728.71
Loans & advances88.1758.6156.7664.1711360.9873.59
Total current assets306232203177332257209
Total current liabilities12810397.7294.7281.3373.8369.71
Net working capital17812910582.03250183139
Total assets1,3921,2561,1961,016970915894
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash21.609.203.2949.396.028.445.12
Net cash from operating activities91.1914914016510177.2457.09
Net cash from investing activities(109)(101)(206)(172)(40.32)(51.83)(32.28)
Net cash from financing activities9.16(35.80)72.14(38.21)(17.25)(27.82)(21.50)
Net change in cash(8.25)12.405.91(46.09)43.36(2.41)3.31
Closing cash13.3921.669.233.3210482.9728.71
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+3.4%+4.7%+17.2%+9.5%+54.5%-13.5%-
EBITDA growth-7.2%-12.3%+24.9%+13.0%+45.7%+5.4%-
PBT growth-14.5%-14.3%+30.4%+21.5%+80.1%-2.7%+12.4%
Net income growth+49.0%-26.5%+24.1%+10.7%+66.0%+57.4%-
Revenue CAGR (3Y)+8.3%+10.3%+25.6%+13.5%+11.8%+3.3%+14.5%
EBITDA CAGR (3Y)+0.6%+7.4%+27.2%+20.2%+14.9%+2.9%+4.4%
Profitability & leverage
Net income margin+12.6%+9.6%+12.5%+11.4%+10.8%+10.2%+5.8%
Return on capital employed+9.9%+12.1%+14.7%+12.7%+11.1%+6.6%+7.3%
Return on net worth+9.5%+7.6%+10.2%+8.6%+8.0%+5.2%+3.5%
Debt / equity0.100.110.080.040.050.060.08
Long-term debt / equity0.080.090.060.030.030.050.07
Interest cover13.7110.723.044.184.828.9415.87
Efficiency & per share
Fixed asset turnover0.991.011.000.870.800.530.63
Inventory turnover40.0244.0542.7435.8932.5324.1335.32
Debtors turnover5.776.978.007.706.914.545.60
EPS (β‚Ή)10.507.809.677.536.463.972.59
Dividend per share (β‚Ή)0.000.001.201.201.001.000.50
Book value per share (β‚Ή)115.97105.5098.8990.4283.9578.6675.34

Investments & Acquisitions by Shalby Hospitals

Shalby Hospitals has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Sanar International Hospitals and Slaney Healthcare.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Specialized healthcare services are provided in cancer care and orthopedics.
sanarhospitals.comGurugram, India2018Jan 2024β€’β€’β€’β€’
Surgical instruments are manufactured by Slaney Healthcare in India.
slaneyhealthcare.comAhmedabad, India2010Sep 2020$9.7M
Premium access

Complete acquisition details for Shalby Hospitals

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Shalby Hospitals

4 dated milestones of Shalby Hospitals across 30 years, from founding to its latest funding, stage changes and deals.

  1. Founded Shalby Hospitals is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Slaney Healthcare.
  4. Acquisition Acquires Sanar International Hospitals.

Similar companies to Shalby Hospitals

Shalby Hospitals has 3 listed similar companies in our database, 2 of them funded. They include Fortis Healthcare, Ujala Cygnus and Narayana Health.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
fortishealthcare.com1996Gurugram, India1,565
Multi-specialty hospital services are provided across India by Fortis Healthcare.
ujalacygnus.com2011Delhi, India$36.74M2,084
A chain of multi-specialty hospitals is operated in India.
narayanahealth.org2000Bengaluru, India$148.2M8,145
A chain of multi-specialty hospitals is operated in India.
Premium access

Detailed similar companies of Shalby Hospitals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Shalby Hospitals

The website of Shalby Hospitals (shalby.org) receives about 36K visits a month.

  • Monthly visits
    36K

    ▲ 19.8% vs previous month

Similar websites

Websites whose visitors overlap most with Shalby Hospitals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
kiranhospital.com
100%
16.7K#1,559,287View details
cims.org
98%
25.6K#1,196,851View details
zydushospitals.com
97%
65.2K#508,541View details
mgmch.org
97%
17.6K#1,398,024View details
hcghospitals.in
97%
27.3K#857,509View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Shalby Hospitals

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Hospitals & Clinical Care

3 companies that operate in the same segment as Shalby Hospitals (Hospitals & Clinical Care) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Maternity, childcare, and fertility services are delivered via hospital chains.
2007Bengaluru, Karnataka, IndiaUSD 204.87 MUSD 140.46 M6,354
Chain of oncology hospitals
1989Bengaluru, Karnataka, IndiaUSD 36.59 MUSD 270.51 M321
Chain of multi-super specialty healthcare hospitals
2004Gurugram, Haryana, IndiaUSD 104.7 MUSD 461.72 M12,240
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Shalby Hospitals

SHALBY: Q2 REVENUE 3.13B RUPEES VS 2.85B (YOY)
Exchange Update β€’ 19 days ago
SHALBY: Q2 CONS NET PROFIT 83M RUPEES VS 83.8M (YOY)
Exchange Update β€’ 19 days ago
SHALBY: Q2 EBITDA 414M RUPEES VS 416M (YOY); Q2 EBITDA MARGIN 13.21% VS 14.58% (YOY)
Exchange Update β€’ 19 days ago
Shalby Says Amit Pathak Resigns As CFO
Reuters β€’ 1 year ago
Premium access

Complete news archive for Shalby Hospitals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shalby Hospitals

Shalby Hospitals was founded in 1994.

Shalby Hospitals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

Ravi Bhandari is the CEO of Shalby Hospitals, as recorded in our data.

Shalby Hospitals has 2,497 employees.

The primary company behind Shalby Hospitals, Shalby Limited, reported revenue of β‚Ή1,168 Cr for FY 2026, up 5% year on year.

Shalby Hospitals was established in 1994 in Ahmedabad, India, as a chain of multi-specialty facilities. Healthcare services across various specialties are provided by the organization, with operations centered in India. The network focuses on medical treatments and patient care in urban and regional areas. Leadership is held by founder Vikram Shah and CEO Ravi Bhandari, supporting expansion in the healthcare sector.

Shalby Hospitals's top competitors include Fortis Healthcare, Ujala Cygnus and Narayana Health.

Yes, Shalby Hospitals is publicly traded on NSE under the ticker symbol SHALBY.

Shalby Hospitals has made 2 acquisitions, including Sanar International Hospitals, and Slaney Healthcare.

Shalby Hospitals is associated with 6 legal entities: Shalby Limited, Vrundavan Shalby Hospitals Limited, Shalby Medtech Limited and others.

The legal entities of Shalby Hospitals currently have 16 directors, including Viral Bhalchandra Shah, Ravi Bhandari, Ronak Jain and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available